Gene · 51062
ATL1: atlastin GTPase 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ATL1: atlastin GTPase 1. Genes, record 51062. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51062
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q8WXF7 | Atlastin-1 | 558 | 14 | Ensembl, GeneID, HGNC |
Source UniProt
Patents23
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38086 | Q8WXF7 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7547 | Q8WXF7 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 481 | Q8WXF7 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 481 | Q8WXF7 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7547 | Q8WXF7 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 6963 | Q8WXF7 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 6963 | Q8WXF7 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 4134 | Q8WXF7 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 109934 | Q8WXF7 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 261 | Q8WXF7 | Espacenet |
1 to 10 of 23
See all 23 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,081
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ATL1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| R01GM107285 | Mechanism and Role of Membrane Fusion by the Atlastin GTPase | 7 | 2025 |
| R01NS072248 | Genome Studies in Hereditary Spastic Paraplegia- Beyond the Exome | 7 | 2025 |
| R01GM122923 | Characterizing the Regulation of Ferroptosis | 6 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 5 | 2025 |
| K08NS123552 | Development of a Translational Research Platform to Understand and treat Defective Protein Trafficking in Childhood-Onset Hereditary Spastic Paraplegia | 4 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,081Source NIH's project files
See all 1,081 nih grantsPapers2,411
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-derived acetylcholine promotes immune evasion in hepatocellular carcinoma by protecting regulatory T cells from ferroptosis. | Int Immunopharmacol | 2026 | 42822277 | PubTator, text mining | PubMed |
| Neutrophil-Driven Inflammation in Pediatric Chronic Recurrent Multifocal Osteomyelitis. | Arthritis Rheumatol | 2026 | 42806909 | PubTator, text mining | PubMed |
| Spatial Association Between Polyamine Metabolism and Lipid Peroxidation in Different Pathological Regions of Glioblastoma. | Biomedicines | 2026 | 42792811 | PubTator, text mining | PubMed |
| Targeting SQLE-Mediated Cholesterol Metabolism to Promote Oxidative Stress and Attenuate Drug Resistance in Osteosarcoma. | Antioxidants (Basel) | 2026 | 42792161 | PubTator, text mining | PubMed |
| Pharmacological targeting of ferroptosis in cancer: mechanisms, tumor immunity, and translational challenges. | Pharmacol Rep | 2026 | 42789241 | PubTator, text mining | PubMed |
| Serum levels of immunoglobulins, tumour markers, and chemokines in gastric cancer patients treated with SOX regimen versus oxaliplatin monotherapy. | J Med Biochem | 2026 | 42780944 | PubTator, text mining | PubMed |
| Ferroptosis in Neurodegenerative Diseases: Iron Dysregulation, GPX4/FSP1 Signaling, and Emerging Neuroprotective Strategies. | Curr Neurovasc Res | 2026 | 42770359 | PubTator, text mining | PubMed |
| Programmed cell death evasion in BRAF V600E-driven primary CNS tumors and thyroid cancer brain metastases. | Front Neurol | 2026 | 42769885 | PubTator, text mining | PubMed |
| Decreased FSP1 expression under chronic hypoxia sensitizes human macrophages towards ferroptosis. | Redox Biol | 2026 | 42759111 | PubTator, text mining | PubMed |
| RNA m6A modification-regulated ferroptosis in cancer: mechanism and therapeutic potential. | Front Cell Dev Biol | 2026 | 42755876 | PubTator, text mining | PubMed |
1 to 10 of 2,411
See all 2,411 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/51062
GET https://conductscience.org/api/genes/v1/51062/patents?page=2